Zscaler, Inc.
255.15USD
+17.3900 (+7.31%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on ZS.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.16▲ | $1.08 | 34 | 0 |
| Next quarter | $1.18▲ | $1.11 | 0 | 1 |
| Current year | $4.91▲ | $4.6 | 2 | 0 |
| Next year | $5.62▲ | $5.44 | 12 | 2 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $1.09 | $1.19 | +0.10 (+9.2%) |
| 2026-04-30 | $1.01 | $1.08 | +0.07 (+7.1%) |
| 2026-01-31 | $0.9 | $1.01 | +0.11 (+12.6%) |
| 2025-10-31 | $0.86 | $0.96 | +0.10 (+11.4%) |
715 ratings from 56 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Freedom Broker | Maintained | Buy | $230 $270 | Oct 22, 2026 |
| DA Davidson | Initiated | Neutral | $215 | Oct 21, 2026 |
| Citigroup | Maintained | Buy | $245 $260 | Oct 15, 2026 |
| Citizens | Maintained | Market Outperform | $210 $265 | Oct 9, 2026 |
| Amerx | Initiated | Buy | $305 | Oct 8, 2026 |
| Macquarie | Maintained | Outperform | $200 $250 | Oct 7, 2026 |
| UBS | Maintained | Buy | $225 $250 | Oct 7, 2026 |
| Citigroup | Maintained | Buy | $205 $245 | Oct 7, 2026 |
| Jefferies | Maintained | Buy | $220 $250 | Oct 7, 2026 |
| Canaccord Genuity | Maintained | Buy | $210 $250 | Oct 7, 2026 |
| BNP Paribas | Reiterated | Outperform | $230 $250 | Oct 7, 2026 |
| Truist Securities | Reiterated | Buy | $200 $250 | Oct 7, 2026 |
| Scotiabank | Maintained | Sector Outperform | $240 $255 | Oct 7, 2026 |
| JP Morgan | Maintained | Overweight | $215 $245 | Oct 7, 2026 |
| Wells Fargo | Maintained | Overweight | $215 $260 | Oct 7, 2026 |
| Barclays | Maintained | Overweight | $220 $225 | Oct 7, 2026 |
| Stephens & Co. | Maintained | Overweight | $225 $265 | Oct 7, 2026 |
| RBC Capital | Reiterated | Outperform | $236 | Oct 7, 2026 |
| TD Cowen | Maintained | Buy | $200 $230 | Oct 7, 2026 |
| Stifel | Maintained | Buy | $200 $235 | Oct 7, 2026 |
| Evercore ISI Group | Maintained | In-Line | $155 $195 | Oct 7, 2026 |
| Guggenheim | Maintained | Buy | $214 $254 | Oct 7, 2026 |
| Wedbush | Maintained | Outperform | $215 $240 | Oct 7, 2026 |
| BTIG | Reiterated | Neutral | — | Oct 7, 2026 |
| Baird | Maintained | Outperform | $230 $285 | Oct 7, 2026 |
132 filings from 22 insiders · 4 buy / 21 sell over 6m
Officers and directors of ZS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Schlossman RobertOfficer, Chief Legal Officer | Grant | 14.2k | — | — | Oct 19, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Grant | 19.9k | — | — | Oct 19, 2026 |
| Geller AdamOfficer, Chief Product Officer | Grant | 19.9k | — | — | Oct 19, 2026 |
| Geller AdamOfficer, Chief Product Officer | ExerciseStock Option (right to buy) | 1.0k | $205.61 | $214k | Oct 12, 2026 |
| Geller AdamOfficer, Chief Product Officer | Sell | 1.0k | $235.95 | $246k | Oct 12, 2026 |
| Geller AdamOfficer, Chief Product Officer | Exercise | 1.0k | $205.61 | $214k | Oct 12, 2026 |
| Geller AdamOfficer, Chief Product Officer | ExerciseStock Option (right to buy) | 24.0k | $205.61 | $4.93M | Oct 9, 2026 |
| Geller AdamOfficer, Chief Product Officer | Sell | 2.1k | $230.00 | $479k | Oct 9, 2026 |
| Geller AdamOfficer, Chief Product Officer | Sell | 21.9k | $225.00 | $4.92M | Oct 9, 2026 |
| Geller AdamOfficer, Chief Product Officer | Exercise | 24.0k | $205.61 | $4.93M | Oct 9, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 100 | $194.76 | $19k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 189 | $195.64 | $37k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 118 | $196.57 | $23k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 3 | $197.32 | $592 | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 9 | $199.71 | $2k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 20 | $201.11 | $4k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 5 | $202.06 | $1k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 36 | $203.15 | $7k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 12 | $204.42 | $2k | Sep 25, 2026 |
| RUBIN KEVINOfficer, Chief Financial Officer | Sell | 20 | $205.35 | $4k | Sep 25, 2026 |
No analyst notes on ZS yet.
Analyst Ratings
45 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 7 | 29 | 11 | 0 | 0 | Buy2.09 |
| 1 mo ago | 7 | 29 | 10 | 0 | 0 | Buy2.07 |
| 2 mo ago | 8 | 29 | 9 | 0 | 0 | Buy2.02 |
| 3 mo ago | 8 | 30 | 8 | 0 | 0 | Buy2.00 |
Members whose judged calls on ZS have played out most reliably.
No settled calls on ZS yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice